KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Operating Leases (2020 - 2025)

Cardlytics (CDLX) has disclosed Operating Leases for 6 consecutive years, with $4.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Leases fell 20.67% year-over-year to $4.8 million, compared with a TTM value of $4.8 million through Dec 2025, down 20.67%, and an annual FY2025 reading of $4.8 million, down 20.67% over the prior year.
  • Operating Leases was $4.8 million for Q4 2025 at Cardlytics, down from $6.8 million in the prior quarter.
  • Across five years, Operating Leases topped out at $9.7 million in Q1 2024 and bottomed at $2.4 million in Q2 2023.
  • Average Operating Leases over 5 years is $5.8 million, with a median of $5.7 million recorded in 2021.
  • The sharpest move saw Operating Leases tumbled 61.89% in 2023, then surged 202.57% in 2024.
  • Year by year, Operating Leases stood at $6.8 million in 2021, then plummeted by 36.69% to $4.3 million in 2022, then surged by 48.42% to $6.4 million in 2023, then fell by 5.59% to $6.0 million in 2024, then dropped by 20.67% to $4.8 million in 2025.
  • Business Quant data shows Operating Leases for CDLX at $4.8 million in Q4 2025, $6.8 million in Q3 2025, and $4.9 million in Q2 2025.